Home
Ra Capital Management reported a 9.9% stake in Mineralys Therapeutics MLYS · 7,796,433 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 9.9%
- Last report
- 9.9% · filed 25/03/17
- Shares held
- 7,796,433 sh
- Class
- Common Stock, par value $0.0001 per share
- Holder
- Ra Capital Management
- Event date
- 25/09/04
- Filed
- 25/09/08
9.9% stake · +0.0pp from the last report
- Stake
- 9.9%
- Last report
- 9.9%
- Since last report
- +0.0pp
Mineralys Therapeutics trades, last 26 weeks
What else happened in Mineralys Therapeutics around then
Filed or reported within 30 days of the trade day · 25/08/05~25/10/04Ra Capital Management's other 5% stake reports
- Ra Capital Management
5% stakeCorbus Pharmaceuticals Holdings
5% stakeCorbus Pharmaceuticals Holdings
CRBP
9.9% stake
1,914,788 sh
9.9% stake
Filed 09/30
- Ra Capital Management
5% stakeBetterLife Pharma
5% stakeBetterLife Pharma
BETRF
9% stake
55,420,000 sh
9% stake
Filed 09/22
- Ra Capital Management
5% stakeSionna Therapeutics
5% stakeSionna Therapeutics
SION
14.3% stake
6,476,193 sh
14.3% stake
Filed 09/21
- Ra Capital Management
5% stakeTyra Biosciences
5% stakeTyra Biosciences
TYRA
19.9% stake
14,130,492 sh
19.9% stake
Filed 09/17
- Ra Capital Management
5% stakeJatt III Acquisition
5% stakeJatt III Acquisition
JTTT
5.1% stake
450,000 sh
5.1% stake
Filed 09/03
